Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial.
Xia S, Duan K, Zhang Y, Zeng X, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang W, Yang Y, Chen W, Gao X, You W, Wang X, Wang Z, Shi Z, Wang Y, Yang X, Li Q, Huang L, Wang Q, Lu J, Yang Y, Guo J, Zhou W, Wan X, Wu C, Wang W, Huang S, Du J, Nian X, Deng T, Yuan Z, Shen S, Guo W, Liu J, Yang X.
Xia S, et al. Among authors: guo w.
Front Immunol. 2022 Jun 24;13:898151. doi: 10.3389/fimmu.2022.898151. eCollection 2022.
Front Immunol. 2022.
PMID: 35812412
Free PMC article.
Clinical Trial.